Kwon, Minsu <br/><br/>
Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  Nov 2016 
 - 3105-3114 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.1080/15384101.2016.1235104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Head and Neck Neoplasms--metabolism<br/>Humans<br/>Models, Biological<br/>NF-kappa B--metabolism<br/>Phthalazines--pharmacology<br/>Piperazines--pharmacology<br/>Poly Adenosine Diphosphate Ribose--metabolism<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Signal Transduction--drug effects<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--metabolism